GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Shiller PE Ratio

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Shiller PE Ratio : 14.21 (As of Jun. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Shiller PE Ratio?

As of today (2024-06-04), Beijing Science Sun Pharmaceutical Co's current share price is ¥6.82. Beijing Science Sun Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.48. Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio for today is 14.21.

The historical rank and industry rank for Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:300485' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.29   Med: 13.87   Max: 19.15
Current: 14.21

During the past years, Beijing Science Sun Pharmaceutical Co's highest Shiller PE Ratio was 19.15. The lowest was 4.29. And the median was 13.87.

SZSE:300485's Shiller PE Ratio is ranked better than
76.31% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.99 vs SZSE:300485: 14.21

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Beijing Science Sun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥-0.396. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.48 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Science Sun Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Shiller PE Ratio Chart

Beijing Science Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 19.77

Beijing Science Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 10.74 14.95 19.77 17.23

Competitive Comparison of Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio falls into.



Beijing Science Sun Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.82/0.48
=14.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Science Sun Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Beijing Science Sun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.396/115.2271*115.2271
=-0.396

Current CPI (Mar. 2024) = 115.2271.

Beijing Science Sun Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.157 98.200 0.184
201409 0.153 98.900 0.178
201412 0.135 99.000 0.157
201503 0.128 99.900 0.148
201506 0.124 99.500 0.144
201509 0.210 100.500 0.241
201512 0.111 100.600 0.127
201603 0.125 102.200 0.141
201606 0.150 101.400 0.170
201609 0.145 102.400 0.163
201612 0.120 102.600 0.135
201703 0.095 103.200 0.106
201706 0.125 103.100 0.140
201709 0.200 104.100 0.221
201712 0.170 104.500 0.187
201803 0.120 105.300 0.131
201806 0.150 104.900 0.165
201809 0.160 106.600 0.173
201812 0.150 106.500 0.162
201903 0.090 107.700 0.096
201906 0.100 107.700 0.107
201909 0.070 109.800 0.073
201912 0.050 111.200 0.052
202003 0.050 112.300 0.051
202006 0.130 110.400 0.136
202009 0.090 111.700 0.093
202012 0.050 111.500 0.052
202103 0.090 112.662 0.092
202106 0.090 111.769 0.093
202109 0.110 112.215 0.113
202112 0.550 113.108 0.560
202203 0.221 114.335 0.223
202206 0.269 114.558 0.271
202209 0.030 115.339 0.030
202212 -0.090 115.116 -0.090
202303 0.002 115.116 0.002
202306 0.518 114.558 0.521
202309 -0.110 115.339 -0.110
202312 -0.200 114.781 -0.201
202403 -0.396 115.227 -0.396

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Science Sun Pharmaceutical Co  (SZSE:300485) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Beijing Science Sun Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Executives
Ma Li Directors, executives
Kong Shuang Quan Executives
Li Jian Hua Director
Ma Biao Directors, executives
Li Zhi Bing Supervisors
Zhang Fan Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines